Bayer Aktie
| 57,52EUR | 0,87EUR | 1,54% |
WKN DE: BAY001 / ISIN: DE000BAY0017
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 100,00 |
| Temasek Holdings Pte Ltd. (Investment Management) | 3,52 |
| Norges Bank Investment Management | 2,98 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 99 762 | 116 998 | 103 824 | 99 538 | 99 637 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,35 | 0,34 | 0,42 | 0,42 | 0,44 |
Bilanz (in Mio. EUR) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 31 238 | 32 197 | 31 760 | 35 002 | 31 994 |
| Summe Anlagevermögen | 50 534 | 87 199 | 86 308 | 72 154 | 73 823 |
| Summe Aktiva | 76 820 | 131 439 | 131 327 | 122 850 | 126 778 |
Bilanz (in Mio. EUR) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 13 733 | 41 222 | 38 971 | 41 630 | 40 803 |
| Summe Fremdkapital | 39 959 | 85 291 | 83 810 | 92 151 | 93 610 |
| Summe Eigenkapital | 36 861 | 46 148 | 47 517 | 30 699 | 33 168 |
| Summe Passiva | 76 820 | 131 439 | 131 327 | 122 850 | 126 778 |
Adresse
| Kaiser-Wilhelm-Allee 1, 51368 Leverkusen | |
| Telefon | +49 (214) 30-1 |
| Internet | http://www.bayer.com |
Management
|
Alan Schultz
Head-North America Project Procurement |
|
Alberto Weisser
Member-Supervisory Board |
|
Andrea Sacher
Member-Supervisory Board |
|
André van Broich
Member-Supervisory Board |
|
Bijoy Sagar
Chief Information Technology Officer |
|
Christian Rommel
Head-Research & Development |
|
Colleen A. Goggins
Member-Supervisory Board |
|
Ertharin Cousin
Member-Supervisory Board |
|
Fei-Fei Li
Member-Supervisory Board |
|
Frank Löllgen
Member-Supervisory Board |
|
Frank Rittgen
Head-Mergers & Acquisitions |
|
Heike Hausfeld
Member-Supervisory Board |
|
Heiko Willem-Jan Schipper
Member-Management Board |
|
Horst Heinz Paul Baier
Member-Supervisory Board |
|
Itziar Canamasas
Head-Oncology Europe, Middle East & Africa |
|
Jürgen Beunink
Senior Manager-Investor Relations |
|
Marianne de Backer
EVP & Head-Global Business Development & Licensing |
|
Martin Hendrix
Senior Director-Business Strategy |
|
Michael Schmidt-Kiessling
Member-Supervisory Board |
|
Norbert W. Bischofberger
Member-Supervisory Board |
|
Norbert Winkeljohann
Chairman-Supervisory Board |
|
Oliver Maier
Head-Investor Relations |
|
Oliver Zühlke
Vice Chairman-Supervisory Board |
|
Otmar D. Wiestler
Member-Supervisory Board |
|
Paul Achleitner
Member-Supervisory Board |
|
Petra Reinbold-Knape
Member-Supervisory Board |
|
Reiner Hoffmann
Member-Supervisory Board |
|
Robert Gundlach
Member-Supervisory Board |
|
Rodrigo Santos
President-Crop Science Division |
|
Ruzha Draganova
Global HR Business Partner |
|
Sarena S. Lin
Chief Transformation & Talent Officer |
|
Simone Bagel-Trah
Member-Supervisory Board |
|
Stefan Oelrich
President-Pharmaceuticals Division |
|
Thomas Elsner
Member-Supervisory Board |
|
Thomas Hoffmann
Head-Treasury |
|
Werner Baumann
Chairman-Management Board & CEO |
|
Wolfgang U. Nickl
Chief Financial Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
